Exercise-Triggered Mitochondrial Transfer: A New Hope for Stroke and Dementia
The devastating impact of stroke and dementia on individuals and society is well-known, with physical rehabilitation and symptom management remaining the primary treatment options. While clot removal or dissolution can be effective within a narrow time frame after a stroke, many patients are left with long-term issues such as difficulty walking, speaking, and memory decline. Exercise has proven beneficial in preventing strokes and improving recovery, but elderly patients often lack the strength to engage in sufficient physical activity.
A groundbreaking study published in the journal MedComm on January 15, 2026, offers a novel approach to stroke prevention and recovery. Led by Research Assistant Professor Toshiki Inaba from the Department of Neurology at Juntendo University School of Medicine in Japan, along with Dr. Nobukazu Miyamoto and Dr. Nobutaka Hattori, the research team explored the biological mechanism of exercise-induced brain protection through mitochondrial migration.
Dr. Miyamoto explains, 'During my research fellowship with Assistant Professor Kazuhide Hayakawa at Massachusetts General Hospital/Harvard Medical School, I observed that mitochondria could travel between cells, leading to the realization that mitochondrial transfer could be harnessed for various therapeutic purposes. This inspired us to investigate intercellular mitochondrial transfer as a potential treatment strategy.'
The study utilized mouse models that mimic stroke and dementia, with some mice performing low-intensity treadmill exercise. Researchers compared brain damage, movement, memory, and changes in brain, muscle cells, and mitochondrial dosage and activity between exercising and non-exercising mice. The results were remarkable, showing that treadmill exercise reduced white matter and myelin damage, improved memory and movement, and mitigated post-stroke complications.
Exercise played a crucial role in increasing mitochondrial levels in muscle and blood, enabling their migration between tissues via platelets. These platelets acted as delivery trucks, transporting mitochondria produced in muscle cells to brain cells, including neurons and supportive cells like oligodendrocytes and astrocytes. Once in the brain, these mitochondria helped damaged brain cells and the surrounding penumbra region survive low-oxygen conditions, supported white matter repair, and reduced post-stroke complications.
The study's implications are far-reaching. Dr. Inaba states, 'Currently, there are limited effective therapies for post-stroke neurological sequelae and no established treatments for vascular dementia progression. While further experiments have revealed technical and biological challenges, our proposed approach holds promise for mitigating neurological sequelae after cerebral infarction. Additionally, the therapeutic applications may extend beyond stroke to mitochondrial diseases and related neurodegenerative disorders.'
This innovative study opens up exciting possibilities for stroke recovery and vascular dementia prevention, potentially benefiting other debilitating brain cell degeneration diseases. If safe and effective in human trials, the benefits of exercise could be harnessed through the transfusion of mitochondria-laden platelets, offering a new and promising avenue for treatment.
